What Fujifilm does

FUJIFILM Holdings Corporation is a diversified Japanese technology conglomerate operating across four business segments: Healthcare, Electronics, Business Innovation, and Imaging. Founded in 1934 as a photographic film manufacturer and headquartered in Minato-ku, Tokyo (TYO: 4901), the company reported ¥3,357.0 billion (~$21.3 billion) in revenue for the fiscal year ending March 31, 2026, with 73,526 employees globally.

The Healthcare segment, which crossed ¥1 trillion in annual revenue in FY ended March 2025, encompasses medical imaging systems (endoscopy, X-ray, MRI, ultrasound, digital pathology), biopharmaceutical CDMO services (cell culture media, iPSC manufacturing, viral vector production through FUJIFILM Cellular Dynamics, FUJIFILM Diosynth Biotechnologies, and FUJIFILM Biosciences), and pharmaceutical products. Recent launches include the EB-710US balloon-less EBUS bronchoscope, ECHELON Smart ZeroHelium MRI, and a 175,000-square-foot iPSC manufacturing facility in Madison, Wisconsin ($200M investment). The Electronics segment supplies semiconductor materials (photoresists, electronic chemicals, CMP slurries, advanced packaging materials under ZEMATESTM) following the 2023 $700M Entegris Electronic Chemicals acquisition, plus PFAS-free PBO for advanced packaging developed with imec. Business Innovation delivers document solutions (Apeos, Revoria Press), cloud workflow (FUJIFILM IWpro with AI Chat), and Microsoft Dynamics 365 ERP services through acquired MicroChannel Services and ETG Global. Imaging covers the Instax instant camera franchise (Mini, Wide, Square formats with razor-and-blades film economics) and X-series mirrorless cameras (X-T30 III, X Half).

Fujifilm monetizes through hardware sales (medical equipment, cameras, printers), recurring consumables (Instax film, printer supplies, medical consumables), professional services (CDMO manufacturing, ERP implementation), technology licensing (color science embedded in Ouster Rev8 LiDAR sensors), and direct enterprise field sales for healthcare systems plus channel partners for business solutions. The company operates manufacturing and service facilities globally and is positioning for tailwinds from Japan's ¥370 trillion strategic investment plan targeting AI, semiconductors, and advanced industries through 2040.

Name

Fujifilm

Legal name

FUJIFILM Holdings Corporation

Website

https://fujifilm.com

Company type

Public

Founded year

1934

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

FUJIFILM Holdings (TYO: 4901) is a diversified Japanese technology conglomerate operating across Healthcare (medical imaging, biopharma CDMO), Electronics (semiconductor materials), Business Innovation (printers, ERP), and Imaging (Instax, mirrorless cameras), serving hospital networks, semiconductor fabs, enterprises, and consumers globally.

Ownership category

akta.pro rank

Product category

Diversified Healthcare, Materials, and Imaging Technology

NAICS

Photographic Film, Paper, Plate, Chemical, and Copy Toner Manufacturing (325992), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Audio and Video Equipment Manufacturing (3343), Computer and Electronic Product Manufacturing (334)

SIC

Surgical & Medical Instruments & Apparatus (3841), Photographic Equipment & Supplies (3861), Electromedical & Electrotherapeutic Apparatus (3845), Optical Instruments & Lenses (3827)

akta.pro primary industry

Photo & Video Output Devices (Printers, Portable Photo Printers, Photo Frames) (CRACAPAL)

akta.pro secondary industries

Lenses & Optical Accessories (Lenses, Filters, Adapters, Teleconverters) (CRACAPAF), Electrical & Electronics Film/Sheet Extrusion (Insulating Films, Display/Optical Films) (IMANACAE), Cameras, Imaging & Drones Distribution (CRAOACAH)

Keywords

• Medical imaging systems
• Biopharmaceutical CDMO services
• Semiconductor materials supply
• Instant photography products
• Enterprise printing solutions

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Healthcare — Medical Devices & Systems: Fujifilm generates revenue from selling and servicing medical imaging equipment including endoscopes, X-ray systems, MRI systems, ultrasound devices, and digital pathology solutions. The segment crossed ¥1 trillion in annual revenue in FY ended March 2025. Equipment sales are supplemented by recurring service contracts and consumables.
2. Healthcare — Bio CDMO & Life Sciences: Fujifilm operates contract development and manufacturing organization (CDMO) services for biopharmaceuticals including cell culture media, iPSC manufacturing, viral vector production, and biologics manufacturing (e.g., $200M iPSC facility investment in Madison, Wisconsin). Revenue from process development services, manufacturing runs, and long-term supply agreements with pharmaceutical clients.
3. Imaging — Consumer Cameras & Instant Photography: Revenue from Instax instant cameras (Mini, Wide, Square formats), X-series mirrorless cameras, lenses, and Instax film consumables. The Instax line operates on a razor-and-blades model with recurring film pack purchases. Products are sold through retail (Amazon, Best Buy) and direct channels.
4. Electronics — Semiconductor Materials: Fujifilm supplies semiconductor fabrication materials including photoresists, electronic chemicals, CMP slurries, and advanced packaging materials. In May 2023, Fujifilm acquired the Electronic Chemicals division of Entegris for approximately $700 million to expand this segment. Revenue is derived from high-volume material supply contracts with semiconductor fabs.
5. Business Innovation — Document Solutions: Fujifilm Business Innovation generates revenue from multifunction printers, production print systems, office solutions, paper, consumables, and managed print services. Revenue combines hardware sales with recurring consumables and service contracts. The segment also provides ERP implementation services (via acquisitions of MicroChannel Services and ETG Global) and cloud services like FUJIFILM IWpro.
6. Licensing & Technology Royalties: Fujifilm licenses its proprietary color science technology to third parties, as demonstrated by the Rev8 LiDAR collaboration with Ouster where Fujifilm's organic color filters are embedded in Ouster sensors. Fujifilm also licenses pharmaceutical compounds (e.g., favipiravir/Avigan developed by Toyama Chemical, part of Fujifilm).

Pricing tiers

Go-to-market motion4 records

Distribution channels6 records

Marketing channels8 records

Core offering

Fujifilm manufactures and sells medical imaging systems (endoscopes, MRI, X-ray, ultrasound, digital pathology), biopharmaceutical CDMO and iPSC manufacturing services, semiconductor materials (photoresists, electronic chemicals, CMP slurries, PFAS-free packaging materials), enterprise printing and document solutions (Revoria Press, Apeos, FUJIFILM IWpro cloud), and consumer photography products (Instax instant cameras, X-series mirrorless cameras, Fujinon lenses). The company serves both enterprise and consumer markets across four business segments: Healthcare, Electronics, Business Innovation, and Imaging.

Product overview

Fujifilm operates through four core business segments: Healthcare, Electronics, Business Innovation, and Imaging. The company has transformed from its photographic film origins into a diversified technology company. In Healthcare, Fujifilm offers endoscopy systems, the EB-710US balloon-less EBUS bronchoscope, MRI systems (ECHELON Smart ZeroHelium), ultrasound systems (ARIETTA Precision), X-ray systems (FDR Nano), and AI-enhanced imaging solutions including ECHELON Synergy. The segment also includes iPSC research products and Bio CDMO services. In Business Innovation, FUJIFILM IWpro cloud service provides AI-powered document workflow automation, alongside multifunction devices and production printing solutions under the Revoria Press brand. The Imaging segment features the popular INSTAX instant camera line (Mini 13, Mini 99, Wide 400), mirrorless cameras (X-T30 III, X Half), and the Fujinon lens family. The company also provides semiconductor packaging materials including PFAS-free PBO under the ZEMATESTM line, and has partnered with Ouster for native color LiDAR technology integration.

Differentiator

Problem solved

Functional benefit

Brands

• INSTAX: Brand for instant cameras and smartphone printers including INSTAX Mini, INSTAX Wide, INSTAX Square formats
• SYNAPSE
• FUJINON
• Apeos
• Revoria Press
• ECHELON
• FDR Nano
• BalanCD

Products and services

• Fujifilm X-T30 III
• Fujifilm X Half
• Fujifilm Instax Mini 13
• Fujifilm Instax Wide 400
• Fujifilm Instax Mini 99
• Fujinon XC 13-33mm F3.5-6.3 OIS
• FUJIFILM IWpro
• FUJIFILM Business Innovation Solutions Enterprise document solutions including multifunction devices, production printing systems, and workflow software. Encompasses Apeos and Revoria Press series for office and production environments.
• Revoria Press Series
• Production Color Printers
• Jet Press FP790
• Endoscopy Systems
• EB-710US Balloon-less EBUS Bronchoscope
• ECHELON Smart ZeroHelium MRI System
• ARIETTA Precision Ultrasound System
• ECHELON Synergy MRI
• FDR Nano Mobile X-ray System
• iPSC Research Products
• ZEMATESTM Product Line
• Inline Raman Measurement System

Quantifiable outcome

• Healthcare segment revenue exceeded ¥1 trillion for FY ended March 2025, a milestone crossed for the first time
• +3 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability14 records

Feature8 records

Partnerships

Ten partnerships are on record, tiered core and moderate.

• Japan Government (Key Beneficiary of National Strategy)coreOthers · 20 June 2026Fujifilm is positioned as a key beneficiary of Japan's government growth strategy targeting approximately ¥370 trillion ($2.3 trillion) in combined public and private investment across 17 strategic sectors by fiscal year 2040. Japan has committed approximately ¥5.7 trillion in semiconductor and AI support since 2021. Fujifilm is among the companies alongside Rapidus, Rohm, Kioxia, Renesas, Sumco, and Kyocera identified as key beneficiaries of the national semiconductor materials strategy.
• HORIBA, Ltd.coreStrategic or Co-development Partner · 16 June 2026Fujifilm Corporation and HORIBA co-developed a high-sensitivity inline Raman measurement system for real-time monitoring of cell culture and purification in biopharmaceutical manufacturing. The system combines HORIBA's Raman spectrometer with Fujifilm's single-use probe and proprietary measurement algorithms, demonstrating approximately 10% improvement in antibody yield vs conventional UV-Vis methods. The companies plan to exhibit at BIO International Convention in San Diego (June 22-25, 2026) and continue verification toward real-world deployment.
• NextCellmoderateStrategic or Co-development Partner · 24 May 2026FUJIFILM Biosciences and NextCell launched a new commercial platform comprised of RUO (Research Use Only) Stromal Cells and Cell Culture Media, combining NextCell's stromal cell products with Fujifilm's cell culture media expertise for drug discovery and research applications.
• Ouster, Inc.coreTechnology or Integration · 19 May 2026Fujifilm Corporation collaborated with Ouster, Inc. to develop the world's first native color LiDAR sensor, the Rev8 OS family. Fujifilm's color science (organic color filters) is integrated at the silicon level into Ouster's L4 Silicon architecture, enabling unified color and 3D depth capture in a single sensor with shared timing, optics, and calibration. The technology targets Physical AI systems for mapping, AI model training, robotics, and autonomous vehicles.
• Virica BiotechcoreStrategic or Co-development Partner · 1 May 2026Virica Biotech and FUJIFILM Biosciences are collaborating under the Canada-Japan Corporate Co-Innovation Program (supported by NRC IRAP advisory services and funding) to optimize Virica's Viral Sensitizer (VSE) formulation for FUJIFILM Biosciences' BalanCD HEK293 media. The partnership aims to significantly improve AAV (adeno-associated virus) productivity and create an off-the-shelf enhancer-media combination for gene therapy manufacturers, addressing high cost and scalability challenges in AAV production.
• Brainlab SEmoderateStrategic or Co-development Partner · 21 April 2026In April 2024, German digital medical technology firm Brainlab SE partnered with FUJIFILM Healare Americas Corporation to integrate Brainlab's surgical navigation platform with Fujifilm's ARIETTA Precision ultrasound system for enhanced neurosurgical imaging solutions. This partnership combines advanced ultrasound imaging with surgical navigation technology.
• Geronimo Power (and Blevins Solar & Storage Project)coreOthers · 21 April 2026FUJIFILM Holdings entered into a Virtual Power Purchase Agreement with Geronimo Power supporting the Blevins Solar & Storage Project in Falls County, Texas (270 MW solar facility). Fujifilm purchases approximately 46% of the project's nameplate capacity (125 MW), offsetting 100% of its group companies' electricity usage in the US and Canada. The project generates 300,000 MWh annually and offsets approximately 90,000 metric tons of CO2 per year (~10% of Fujifilm's global annual emissions). The solar park became fully operational in March 2026.
• ETG Global Information Technology Services Inc. (Acquisition)coreChannel Partner/ Reseller/ Distributor · 26 February 2026FUJIFILM Business Innovation acquired ETG Global Information Technology Services Inc. (to be renamed FUJIFILM ETG Global Inc. upon completion on March 2, 2026). ETG Global is a Microsoft Dynamics 365 ERP implementation partner operating in Turkey, the US, and Canada, holding the Microsoft 'INNER CIRCLE' award (top 1% of Microsoft partners). The acquisition brings approximately 100 IT engineers and advanced training expertise, combining ETG's technical talent infrastructure with Fujifilm's delivery capabilities in Japan and Australia.
• Entegris, Inc. (Electronic Chemicals Division — Acquisition)coreOthers · 1 October 2023FUJIFILM Corporation acquired the Electronic Chemicals division of Entegris, Inc. for approximately $700 million in October 2023, expanding its portfolio in semiconductor materials and high-purity process chemicals for semiconductor fabrication.
• MicroChannel Services (Acquisition)moderateChannel Partner/ Reseller/ Distributor · 28 February 2023Fujifilm Business Innovation acquired Australian IT services provider MicroChannel Services (rebranded to Fujifilm MicroChannel Services), aiming to strengthen Fujifilm's enterprise resource planning (ERP) systems and services business in Australia, with key leadership changes announced.

Scale indicators15 records

Recent moves1 record

Expansion highlights5 records

Broad incumbents

• GE HealthCare: GE HealthCare is a broad incumbent peer in medical imaging systems (MRI, CT, ultrasound, X-ray), directly competing with Fujifilm's healthcare portfolio. GE operates at greater scale with a broader product portfolio while Fujifilm has a stronger endoscopy focus.
• Hologic: Hologic is a broad incumbent in women's health imaging and diagnostics, overlapping with Fujifilm's breast imaging mammography and digital pathology offerings. Both serve hospital and clinical laboratory customers with diagnostic solutions.
• Philips (Royal Philips): Philips is a broad incumbent peer in healthcare technology including diagnostic imaging, ultrasound, and patient monitoring, overlapping with Fujifilm's healthcare offerings. Both target global hospital networks with integrated diagnostic and treatment solutions.

Direct peers

• Ricoh: Ricoh is a direct peer in office multifunction printers, production printing, and document workflow solutions. Both Japanese conglomerates have pivoted from photographic/imaging heritage into enterprise document and IT services markets.
• Sony Group: Sony's Imaging & Sensing Solutions division competes directly with Fujifilm in mirrorless cameras (Alpha series), broadcast lenses, and image sensors, while Sony's medical business overlaps in healthcare imaging. Both companies leverage Japanese consumer electronics heritage into professional imaging markets.
• Canon: Canon competes with Fujifilm across mirrorless cameras (EOS R system), medical imaging (Canon Medical Systems), and office/production printing. Both have transformed from camera-centric businesses into diversified imaging and healthcare portfolios, often competing in the same hospital procurement deals.
• Eastman Kodak: Kodak is a historical peer in photographic film, instant cameras, and printing. While Kodak operates at much smaller scale today, both share heritage in photographic film and now compete in commercial printing, packaging, and specialty materials markets.
• Olympus: Olympus is a direct peer in medical endoscopy, competing head-to-head with Fujifilm in bronchoscopy, GI endoscopy, and surgical endoscopy markets. Both serve the same hospital customers with overlapping product lines in minimally invasive diagnostics.
• Konica Minolta: Konica Minolta competes with Fujifilm Business Innovation in office multifunction printers, production print, and inkjet systems. The two Japanese companies share office printing customers, healthcare imaging adjacencies, and have established the joint venture Global Procurement Partners Corp. (January 2025).

Emerging players

• Ouster: Ouster is an emerging player partner in LiDAR sensors that embeds Fujifilm's organic color filter technology at the silicon level. The two companies are co-developing native color LiDAR for autonomous vehicles, robotics, and Physical AI systems, representing a unique collaboration in the sensing market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/FUJIFILMBusinessInnovation
• LinkedInlinkedin.com/company/fujifilmcorporation
• Xx.com/fujifilm
• Facebookfacebook.com/fujifilm.community

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries20 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A15 records

Investments25 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fujifilm